Detection of colorectal cancer in urine using DNA methylation analysis

Abstract Colorectal cancer (CRC) is the second leading cause for cancer-related death globally. Clinically, there is an urgent need for non-invasive CRC detection. This study assessed the feasibility of CRC detection by analysis of tumor-derived methylated DNA fragments in urine. Urine samples, incl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: S. Bach, I. Paulis, N. R. Sluiter, M. Tibbesma, I. Martin, M. A. van de Wiel, J. B. Tuynman, I. Bahce, G. Kazemier, R. D. M. Steenbergen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1b71f26446b74fb78e114a936d66f822
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b71f26446b74fb78e114a936d66f822
record_format dspace
spelling oai:doaj.org-article:1b71f26446b74fb78e114a936d66f8222021-12-02T14:16:42ZDetection of colorectal cancer in urine using DNA methylation analysis10.1038/s41598-021-81900-62045-2322https://doaj.org/article/1b71f26446b74fb78e114a936d66f8222021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81900-6https://doaj.org/toc/2045-2322Abstract Colorectal cancer (CRC) is the second leading cause for cancer-related death globally. Clinically, there is an urgent need for non-invasive CRC detection. This study assessed the feasibility of CRC detection by analysis of tumor-derived methylated DNA fragments in urine. Urine samples, including both unfractioned and supernatant urine fractions, of 92 CRC patients and 63 healthy volunteers were analyzed for DNA methylation levels of 6 CRC-associated markers (SEPT9, TMEFF2, SDC2, NDRG4, VIM and ALX4). Optimal marker panels were determined by two statistical approaches. Methylation levels of SEPT9 were significantly increased in urine supernatant of CRC patients compared to controls (p < 0.0001). Methylation analysis in unfractioned urine appeared inaccurate. Following multivariate logistic regression and classification and regression tree analysis, a marker panel consisting of SEPT9 and SDC2 was able to detect up to 70% of CRC cases in urine supernatant at 86% specificity. First evidence is provided for CRC detection in urine by SEPT9 methylation analysis, which combined with SDC2 allows for an optimal differentiation between CRC patients and controls. Urine therefore provides a promising liquid biopsy for non-invasive CRC detection.S. BachI. PaulisN. R. SluiterM. TibbesmaI. MartinM. A. van de WielJ. B. TuynmanI. BahceG. KazemierR. D. M. SteenbergenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
S. Bach
I. Paulis
N. R. Sluiter
M. Tibbesma
I. Martin
M. A. van de Wiel
J. B. Tuynman
I. Bahce
G. Kazemier
R. D. M. Steenbergen
Detection of colorectal cancer in urine using DNA methylation analysis
description Abstract Colorectal cancer (CRC) is the second leading cause for cancer-related death globally. Clinically, there is an urgent need for non-invasive CRC detection. This study assessed the feasibility of CRC detection by analysis of tumor-derived methylated DNA fragments in urine. Urine samples, including both unfractioned and supernatant urine fractions, of 92 CRC patients and 63 healthy volunteers were analyzed for DNA methylation levels of 6 CRC-associated markers (SEPT9, TMEFF2, SDC2, NDRG4, VIM and ALX4). Optimal marker panels were determined by two statistical approaches. Methylation levels of SEPT9 were significantly increased in urine supernatant of CRC patients compared to controls (p < 0.0001). Methylation analysis in unfractioned urine appeared inaccurate. Following multivariate logistic regression and classification and regression tree analysis, a marker panel consisting of SEPT9 and SDC2 was able to detect up to 70% of CRC cases in urine supernatant at 86% specificity. First evidence is provided for CRC detection in urine by SEPT9 methylation analysis, which combined with SDC2 allows for an optimal differentiation between CRC patients and controls. Urine therefore provides a promising liquid biopsy for non-invasive CRC detection.
format article
author S. Bach
I. Paulis
N. R. Sluiter
M. Tibbesma
I. Martin
M. A. van de Wiel
J. B. Tuynman
I. Bahce
G. Kazemier
R. D. M. Steenbergen
author_facet S. Bach
I. Paulis
N. R. Sluiter
M. Tibbesma
I. Martin
M. A. van de Wiel
J. B. Tuynman
I. Bahce
G. Kazemier
R. D. M. Steenbergen
author_sort S. Bach
title Detection of colorectal cancer in urine using DNA methylation analysis
title_short Detection of colorectal cancer in urine using DNA methylation analysis
title_full Detection of colorectal cancer in urine using DNA methylation analysis
title_fullStr Detection of colorectal cancer in urine using DNA methylation analysis
title_full_unstemmed Detection of colorectal cancer in urine using DNA methylation analysis
title_sort detection of colorectal cancer in urine using dna methylation analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1b71f26446b74fb78e114a936d66f822
work_keys_str_mv AT sbach detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT ipaulis detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT nrsluiter detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT mtibbesma detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT imartin detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT mavandewiel detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT jbtuynman detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT ibahce detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT gkazemier detectionofcolorectalcancerinurineusingdnamethylationanalysis
AT rdmsteenbergen detectionofcolorectalcancerinurineusingdnamethylationanalysis
_version_ 1718391652525015040